Your browser doesn't support javascript.
loading
Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method.
Yun, Hanool; Kim, Sun-Hee; Kim, Seung-Hee; Park, Hae-Min; Jeong, Hee-Jin.
Afiliación
  • Yun H; Department of Biological and Chemical Engineering, Hongik University, Sejong-si, Republic of Korea.
  • Kim SH; Industry-Academia Cooperation Foundation, Hongik University, Sejong-si, Republic of Korea.
  • Kim SH; Department of Biological and Chemical Engineering, Hongik University, Sejong-si, Republic of Korea.
  • Park HM; Department of Chemical Engineering and Applied Chemistry, Chungnam National University, Daejeon, Republic of Korea.
  • Jeong HJ; Department of Biological and Chemical Engineering, Hongik University, Sejong-si, Republic of Korea.
Biotechnol J ; 19(7): e2300745, 2024 Jul.
Article en En | MEDLINE | ID: mdl-39014926
ABSTRACT
We developed a method to produce a soluble form of a single-chain fragment variable (scFv) targeting human epithelial growth factor receptor 2 (HER2) in Escherichia coli. By optimizing the orientations of the variable heavy (VH) and variable light (VL) domains and the His-tag, we identified the HL-His type antibody with the highest HER2-binding activity. Purification of HL-His yielded 40.7 mg from a 1 L culture, achieving >99% purity. The limit of detection was determined to be 2.9 ng, demonstrating high production yield, purity, and sensitivity. Moreover, we successfully labeled HER2+ cell lines with fluorescent dye-conjugated scFv, resulting in a significantly higher observed signal-to-background ratio, compared to that of HER2- cell lines. This highlights the potential of these fluorescent scFvs as valuable probes for HER2+ breast cancer diagnostics. Notably, the process for the complete scFv production was streamlined and required only 4-5 days. Additionally, the product maintained its activity after freeze storage, allowing for large-scale production and a wide range of practical applications.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Receptor ErbB-2 / Escherichia coli / Anticuerpos de Cadena Única Límite: Humans Idioma: En Revista: Biotechnol J Asunto de la revista: BIOTECNOLOGIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Receptor ErbB-2 / Escherichia coli / Anticuerpos de Cadena Única Límite: Humans Idioma: En Revista: Biotechnol J Asunto de la revista: BIOTECNOLOGIA Año: 2024 Tipo del documento: Article
...